Nanomedicine News

RSS

Selecta Biosciences Awarded Grant to Advance Therapeutic Nicotine Vaccine

Selecta Biosciences, Inc., a biopharmaceutical company developing synthetic nanoparticle vaccines and immunotherapies, today announced that it has been awarded a grant for $3 million from the National Institute on Drug Abuse (NIDA), an institute within the U.S. National Institutes of Health (NIH).

17 Aug 2010

Researchers Develop Nanocoating That Safely Kills MRSA on Contact

Building on an enzyme found in nature, researchers at Rensselaer Polytechnic Institute have created a nanoscale coating for surgical equipment, hospital walls, and other surfaces which safely eradicates methicillin resistant Staphylococcus aureus (MRSA), the bacteria responsible for antibiotic resistant infections.

16 Aug 2010

New Way for Drug Delivery into Tumors Using Nanoparticles

Clinical trials using patients’ own immune cells to target tumors have yielded promising results. However, this approach usually works only if the patients also receive large doses of drugs designed to help immune cells multiply rapidly, and those drugs have life-threatening side effects.

16 Aug 2010

Methodist Hospital Research Institute Appoints Biomedical Nanotechnology Expert as New CEO

Mauro Ferrari, Ph.D, an internationally recognized leader, collaborator and scientist specializing in biomedical nanotechnology, was named President and CEO of The Methodist Hospital Research Institute today. “...

13 Aug 2010

Researchers Fabricate Silk Metamaterial Composite at Terahertz Frequency

Researchers at the Tufts University School of Engineering and Boston University have fabricated and characterized the first large area metamaterial structures patterned on implantable, bio-compatible silk substrates. ...

13 Aug 2010

Scientists Develop New Gene-Delivery System Using Venom-Based Nanoparticles

An ingredient in the venom of the "deathstalker" scorpion could help gene therapy become an effective treatment for brain cancer, scientists are reporting. The substance allows therapeutic genes — gene...

12 Aug 2010

EUREKA Grant Helps to Design Nanofiber-Based Polymer Thin Films for Tumor Treatment

The Georgia Institute of Technology has received a EUREKA grant from the National Institutes of Health (NIH) to design a new way to treat invasive brain tumors by capturing the migrating cells that spread the disease.

From Georgia Institute of Technology 12 Aug 2010

Arrowhead Research Enters Option Agreement for Obesity-Treating Technology

Arrowhead Research Corporation today announced that it has signed an option agreement with The University of Texas MD Anderson Cancer Center to negotiate a license in a defined field to a class of compounds that is believed to kill fat tissue by specifically targeting the blood vessels that supply it.

From Arrowhead Pharmaceutical 11 Aug 2010

Smart Nanomaterial Can Improve Lives of Glaucoma Sufferers

A "smart" nanomaterial recently developed at the University of Dayton Research Institute for multi-purpose use in aircraft coatings, wind turbines and other large-scale commercial applications may also lead to ...

11 Aug 2010

Innovative Method Enabling Nanomachines to Release Drugs Inside Living Cancer Cells

Scientists from UCLA's California NanoSystems Institute and Korea's Yonsei University have developed an innovative method that enables nanomachines to release drugs inside living cancer cells when activated remotely by an oscillating magnetic field.

10 Aug 2010